Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure

Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy

Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)

informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia

Breast Cancer WEight Loss Study (BWEL Study)

The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia

PRECISION GRX Registry